Peptide Regulation, Delivery, and Longevity-Stacking Safety

Unregulated peptides and clinic-style marketing remain linked to retatrutide overdose, dosage confusion, prohibited compounding, mislabeled products, social-media stacking, unapproved canine use, consumer patches, and physician-certification programs. New guidance-oriented coverage reinforces the distinction between approved peptide medicines and poorly studied products, while oral-delivery and Bodybuilding.com commercialization signals do not establish superior efficacy or safety.